News

The Biotechnology & Biotherapy team, created by Dr. Jacques Mallet and presently directed by Dr. Philippe Ravassard, at Paris Brain Institute, in collaboration with the Pole of Therapeutic Innovation in Neuropsychiatry at the Servier Research...

Alzheimer disease is a major source of preoccupation. A real issue for public health at a global scale, its socio-economic consequences are important. Synonym for cognitive deterioration, it is difficult to live with for the patient but also his...

6 genetic risk factors for Parkinson’s disease have been discovered thanks to a study conducted by an international consortium of researchers, including Professor Alexis Brice’s team at the Brain and Spine Institute – Institut du Cerveau - ICM...

Neuroscience, Ethics and Society (NES) is an initiative of Institut du Cerveau - ICM, for the purpose of integrating ethics and neuroscience through education. Co-Directors of the project are Yves Agid, MD, PhD and Thomasine Kushner, PhD. To...

A research team of the Institut du Cerveau - ICM institute took part to an international study identifying 18 new genes implicated in hereditary spastic paraplegias (HSP). This work, published on January the 31th on the prestigious website of the...

A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the...

The illustration of this article is on the cover of the latest issue of the journal “Brain, a Journal of Neurology”

Hereditary Spastic Paraplegia (HSP) are a genetically heterogeneous group of invalidating neurological disorders characterized by a progressive difficulty walking due to stiff legs (spastic) and additional neurological signs like epilepsy, ataxia...

The aim of Dr A. Sittler, from the Alexis Brice and Giovanni Stevanin team, is to develop a new therapeutic strategy for the spinocerebellar ataxia SCA7.

Henry Raker came to the Institut du Cerveau - ICM today and gave to Pr Gérard Saillant the cheque of the donation made on Ball XX on september 2012. He told us how fantastic was the BB Cycle Challenge, that just ended on 26th of May. We thank all the...

A research team directed by Giovanni Stevanin and Alexis Brice from the Brain and Spine Institute, in collaboration with other teams of the international SPATAX network (coordinator, Alexandra Durr), have identified 3 new causative genes in...

MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has...